Medpace: Long-Term Owners Have To Stomach Short-Term Volatility

everythingpossible/iStock via Getty Images The following segment was excerpted from this fund letter. Medpace ( NASDAQ: MEDP ) declined during the quarter as bookings growth decelerated and concern around increasing clinical trial cancellations accelerated during the quarter. The reality is that Medpace's clinical.